PMHP Flashcards

1
Q

ottawa charter for health promotion (5)

A
  1. build healthy public policy
  2. create supportive environment
  3. strengthen community action
  4. develop personal skills
  5. reorient health services
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

different barriers to health which could cause inequality

A
  • language
  • lack of familiarity with health services
  • culture
  • racism
  • incidence of unemployment
  • tendency to reside in disadvantaged areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

self efficacy

A

patient’s belief that they can succeed at a particular task or behaviour & that is will result in a valued outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

subjective norms

A

perceptions of social norms & expectations to comply with them e.g. what friends and family do

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

implementation intention

A

basically the planning of how a set goal will be achieved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

locus of control

A

similar to self efficacy in that it is the patient’s belief that their dental health is under their own control - if they do not believe this then they are less likely to adhere to advice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

steps of behavioural change

A
  • precontemplators; those not interested
  • contemplators; maybe in the future
  • preparation; wanting to do it right now
  • action; those doing it now
  • maintenance; those keeping it up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how to aid behavioural change

A

establish rapport
set an agenda
assess readiness to change
exchange information
resistance - if misjudged their want to change back off & remind them it is their own personal choice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

molecule used to fluoridate water

A

hydrofluorosilicic acid H2SiF6
or
sodium fluorosilicate Na2SiF8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

best use of fluoride to reduce dental caries

A

topical fluoride i.e. varnish

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

community / individual based fluoride delivery methods

A

community - school water, salt, milk,
individual - varnish, rinses, supplements, toothpastes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fluoride varnish

A

applied 2-4 times per year
22,600ppmF
form of fluoride is sodium fluoride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

dosage of fluoride supplements

A

0-6mths = 0mgF- daily
6mths - 3yrs = 0.25mgF- daily
3-6yrs = 0.5mgF- daily
6+ yrs = 1mgF- daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

amount of toothpaste for <2 & >2 years

A

<2yrs = 1000ppmF smear
>2yrs = 1000ppmF pea sized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

childsmile nursey & school

A

targeted to nurseries & primary schools in higher priority areas (judged by SIMD); there will be 6 monthly fluoride varnish applications to children, fissure sealants & follow up of non regular dental attending children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

units per week for men & women

A

max 14 units consumed over 2-3 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

alcohol management

A

part of SIGN 74
states that GPs & other primary care professionals should opportunistically identify hazardous & harmful drinkers then deliver a brief intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

screening tools for alcoholism

A

AUDIT (alcohol use disorders identification test) is often seen as the gold standard but FAST (fast alcohol screen test) is often used as it is quicker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

blood alcohol concentration

A

will peak 1hr after drinking on an empty stomach and will be removed at a rate of 15mg/100ml/hr
women have smaller blood volume & lower alcohol dehydrogenase in their stomach so more alcohol is absorbed before it is metabolised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

levels of intoxication

A
  • 80mg/100ml = current legal driving limit in UK (35mg/100ml on breath which is decreased to 22 in scotland)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

nicotine replacement therapy

A
  • reduces severity of withdrawal symptoms
  • reduces desire to smoke
  • can delay weight gain
  • can reduce relapse
  • can provide coping mechanism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

nicotine patches

A

suit moderately dependent smokers (10-20 a day)
contraindications = widespread dermatological conditions
designed to be used over a 12wk period
last 16-24hrs
regular release throughout day so not suitable when urge to smoke is strong

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

nicotine gum

A

available in 2mg & 4mg strengths with higher one suiting >20 a day smoker
no more than 10 pieces per day should be chewed
suits irregular smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

nicotine microtabs

A

small tablets placed sublingually & will suit both heavy & light smokers
should be in doses of 24 & 40 a day over 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

5 A’s for quitting

A

ASK
ADVISE
ASSESS
ASSIST
ARRANGE FOLLOW UP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

contented smokers should be given advice on the 5R’s

A

emphasise relevant benefits of quitting
emphasise risks of continuing to smoke
list rewards of stopping
discuss roadblocks to quitting
emphasise that repeat attempts are more successful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

2 main laws relating to drugs in UK

A

Medicines Act 1968
Misuse of Drugs Act 1971

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

oral complications of drug use

A

poor OH
xerostomia
sugar craving
high caries rate
poor perio
smoking
ANUG
low self esteem
trauma
poor attendance
dental anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

methadone

A

synthetics opiate analgesic
mixed with sugary green syrup; will continually occupy muscarinic opioid receptors which is thought to stabilise neurochemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

epidemiology

A

helps determine frequency of a disease within certain risk factors and can assess people’s risk of disease
can be used to evaluate effects of any interventions that have been used and will help with evidence based approaches to health measures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

prevalence

A

measure of all individuals affected by a certain disease (if divided by total it gives percentage affected)
it is used to show how common a certain disease actually is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

incidence

A

number of new cases of a certain disease that are currently occurring

33
Q

methods used for sampling (4)

A
  1. simple random sample
  2. systemic sample - individuals selected at regular intervals from a population list
  3. stratified sample - ensures small sub groups are adequately represented in a sample
  4. cluster sample - use of groups as sampling units
34
Q

requirements of an ideal index

A
  • clear, unambiguous, non-subjective
  • correspond with clinically important stages of disease
  • indicate tx needed
  • within examiner’s ability
  • reproducible
  • not time consuming
  • acceptable to ptx
  • amenable to statistical analysis
  • allow comparison with other studies
    indices used to measure disease
35
Q

eg of index

A

DMFT - decayed, missing & filled teeth

36
Q

limitations of DMFT

A
  • if teeth XLA for reasons other than caries this is a misrepresentation
  • can be difficult to visualise interproximal areas
  • can be difficult differentiating fissure sealant from restorations
  • can be influenced by past disease activity
  • cannot be used for root caries
37
Q

what is a risk factor

A

an environmental, behavioural or biological factor confirmed by temporal sequence usually increasing probability of disease occurring
if absent or removed it reduces probability
both causes & determinants are considered risk factors for disease development

38
Q

cause

A

external agent which results in disease in susceptible individuals

39
Q

determinant

A

attribute or circumstance which affects liability of an individual to be exposed, when they will be exposed and to develop the disease e.g. socio-economic status

40
Q

confounding variable

A

particular type of extraneous variable which for some reason has been left uncontrolled. the result is that on looking at findings of an experimental study, rather than only one possible variable exerting influence on outcome, there are found to be others, which are said to be confounding the results

41
Q

3 common indices of risk

A
  1. absolute
  2. attributable
  3. relative
42
Q

absolute risk

A

most basic measure which gives incidence rates of a disease amongst people exposed to an agent, however it assumes no risk is incurred by those not exposed to the agent

43
Q

attributable risk

A

this is the difference between the incidence rates of both exposed and non exposed groups; this represents the risks attributable to a factor being investigated

44
Q

risk ratio

A

is a ratio of the incidence rate in the exposed group to the incidence rate in the non exposed group; this will measure the proportion of increase (or decrease) of disease in the exposed group while making allowances for the frequency of the disease amongst those not exposed to the harmful agent

45
Q

cohort study

A

a prospective study where a group of people who have not yet got the disease are recruited for a
study and their risk factors are assessed. They will be observed over a period of time to measure the
frequency of occurrence of disease among those exposed to a risk factor and those not exposed
frequency of occurrence of disease

46
Q

case control study

A

restrospective study in which people with a disease are compared to those free from disease and their histories traced to find out any exposure to suspect harmful agents
may be less robust that cohort studies as it depends on patient remember their risk factors
could be used for preliminary investigation of a hypothesis before being followed by cohort study if possible
risk ratio cannot be found so instead an odds ratio is found

47
Q

main study providing risk factors for dental caries

A

vipeholm study

48
Q

evidence levels for different types of studies in order from best to worst

A
  1. systematic cochrane review & RCT
  2. cohort
  3. case control
  4. case report / series
  5. narrative review, editorial
49
Q

case report / series

A

this is a report on a single patient or series of patients with an outcome of interest however there is no control group involved
they should be used for identifying a new disease outcome & hypothesis generation but they cannot be used to demonstrate valid statistical associations due to their lack of control group

50
Q

cross sectional study

A

observation of a defined population at a single point in time or time interval
this is where the exposure & outcome are determined at the same time
can be use for estimating prevalence of disease & investigating potential risk factors
disadv are that the causality may be vague & these factors can be easily confused with confounding factors; likely to be recall bias

51
Q

case control study

A

study of people with a disease and a suitable control group without the disease; they will then be asked if they had a particular risk factor to see whether it played any part in their disease - useful when looking at potential causes of a disease
causes can be easily confused with confounding variables, there may be recall & selection bias and selection of controls may not be suitable, may be incorrect time relationships between the two so exposure may not have occurred before the disease

52
Q

cohort study

A

group of individuals established then their exposure measured
they are followed up over a period of time & those that develop the disease are identified
useful for estimating incidence of a disease, investigating causes of disease, determining prognosis, timing & direction of events of disease

53
Q

issues with cohort study (5)

A
  1. controls often difficult to identify
  2. confounding variables likely to interfere
  3. blinding is difficult
  4. large samples are needed for rarer diseases
  5. very expensive & time consuming
54
Q

4 key design elements of RCT

A
  1. specification of participants (so the inclusion / exclusion criteria)
  2. comparison (control group)
  3. randomisation
  4. blinding
55
Q

specification of participants

A

must be unambiguous i.e. not open to interpretation e.g. ptx age / severity of disease

56
Q

comparison

A

RCT must have control group which gets the placebo

57
Q

randomisation

A

describes how subjects are allocated to treatments - researcher & participant must not be the ones to do the allocation as there would be bias involved
this means any participant has an equal chance of being in the placebo group as being in the drug group - this should be done via computer

58
Q

blinding

A

RCT should be double blinded - this means participant & researcher must not be aware of treatment given to patients; if they were aware this may influence the results

59
Q

risk ratio

A

aka relative risk
can be devised once RCT undertaken & will describe whether there is a change between the placebo group or not, and by how much of a change there is
e.g. drug group was 63% but placebo was 18% so 63/18 means risk ratio = 3.42

60
Q

confidence intervals

A

95% confidence interval used
if the final confidence interval contains 1 then there is insufficient evidence of a difference but if it doesn’t there is sufficient evidence there is a difference between the two
e.g. if risk ratio was 3.42 and confidence interval was 1.52-7.73 there was sufficient evidence the drug was effective

61
Q

systematic review

A

different RCTs pooled together to realise the risks or benefits of a particular treatment
explicit search strategy to include all papers without prejudice then removing those with a low quality of evidence
highlights where more evidence is needed & when enough has been produced
will also identify flawed studies

62
Q

meta analysis

A

optional part of systematic review; it combines the statistical results of studies for a pooled estimate of treatment effect across the studies

63
Q

6 dimensions of quality in healthcare

A
  1. person centred
  2. safe
  3. efficient
  4. effective
  5. equitable
  6. timely
64
Q

what SIGN guidelines we should know about

A

SIGN 43 - management of unerupted & impacted 3rd molar teeth 2000
SIGN 47 - preventing dental caries in children at high caries risk 2000
SIGN 87 - prevention and management of dental decay in pre school child 2005
SIGN 90 - diagnosis and management of head and neck cancer 2006

65
Q

SDCEP

A

scottish dental clinical effectiveness programme
recommendations based on:
- current legislation or professional regulations
- group consensus after critical evaluation of evidence
- group consensus after considering expert opinion

66
Q

6 factors of clinical governance

A
  1. education & training
  2. clinical audit
  3. clinical effectiveness
  4. research & development
  5. openness
  6. risk management
67
Q

capacity

A

A - act
M - make decision
C - communicate
U - understand
R - retain

68
Q

legislation regarding capacity

A

Adults with Incapacity (Scotland) Act 2000

69
Q

what information must be given to patient to allow them to make decisions

A
  • diagnosis
  • treatment options
  • risks & complications
  • treatment plan and cost
  • impact of no treatment
70
Q

legislation for equality in dentistry

A

equality act 2010

71
Q

protected characteristics

A

age
disability
gender reassignment
marriage & civil partnership
pregnancy & maternity
race & ethnicity
religion & belief
sex
sexual orientation

72
Q

diversity

A

acknowledgement of alterity amongst people in terms of their community, culture, beliefs, life experiences & individuality

73
Q

equality v equity

A

equality = fairness of opportunity and observing the rights of people so their alterity is not discriminated against
equity = to treat equals equally and unequals unequally i.e. certain inequalities demand special measures to ensure fairness

74
Q

4 main communication skills for guiding style

A

OARS
O - open questions
A - affirmation (appreciation for patient efforts)
R - reflective listening
S - summary

75
Q

types of domestic abuse

A
  1. verbal
  2. emotional
  3. physical
  4. sexual
  5. financial
76
Q

who is most at risk of domestic abuse

A
  • women aged 16-24
  • men aged 16-19
  • long term illness / disability
  • mental health problems
  • women who are separated / separating
  • pregnancy
77
Q

signs of domestic abuse

A

repeated injuries
bruises at different stages of healing
dental injuries
unlikely explanations for injury
facial bruising
strangle marks around the neck
delay in seeking help for injuries
soft tissue bruising

78
Q

AVDR intervention for domestic violence

A

ASK, VALIDATE, DOCUMENT, REFER
Ask - about abuse in a private setting
Validate - show concern, removes blame & shows that you believe them & taking it seriously
Document - be specific & detailed, use ptx own words & clinical notes
Refer - means ‘signposting’ to appropriate services i.e. scottish domestic abuse helpline